Avalo Therapeutics, Inc. (AVTX): S-3ASR filed Nov 5, 2026

Form type

S-3ASR

Filing date

Nov 5, 2026

Accession number

0001104659-26-123072

Filer

Avalo Therapeutics, Inc. (CIK 1534120)